Search Results - Maria M. Rubinstein
- Showing 1 - 2 results of 2
-
1
Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma by Sherry Shen, Maria M. Rubinstein, Kay J. Park, Jason A. Konner, Vicky Makker
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer by Anastasia Navitski, Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal, Diana L. Mandelker, Karen Cadoo, Roisin E. O'Cearbhaill
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book